Amphetamine alters Ras-guanine nucleotide-releasing factor expression in the rat striatum in vivo.
Ras-guanine nucleotide-releasing factors (Ras-GRFs) are densely expressed in neurons of the mammalian brain. As a Ras-specific activator predominantly concentrated at synaptic sites, Ras-GRFs activate the Ras-mitogen-activated protein kinase (Ras-MAPK) cascade in response to changing synaptic inputs, thereby modifying a variety of cellular and synaptic activities. While the Ras-MAPK cascade in the limbic reward circuit is well-known to be sensitive to dopamine inputs, the sensitivity of its upstream activator (Ras-GRFs) to dopamine remains to be investigated. In this study, the response of Ras-GRFs in their protein expression to dopamine stimulation was evaluated in the rat striatum in vivo. A single systemic injection of the psychostimulant amphetamine produced an increase in Ras-GRF1 protein levels in both the dorsal (caudoputamen) and ventral (nucleus accumbens) striatum. The increase in Ras-GRF1 proteins was dose-dependent. The reliable increase was seen 2.5h after drug injection and returned to normal levels by 6h. In contrast to Ras-GRF1, protein levels of Ras-GRF2 in the striatum were not altered by amphetamine. In addition to the striatum, the medial prefrontal cortex is another forebrain site where amphetamine induced a parallel increase in Ras-GRF1 but not Ras-GRF2. No significant change in Ras-GRF1/2 proteins was observed in the hippocampus. These data demonstrate that Ras-GRF1 is a susceptible and selective target of amphetamine in striatal and cortical neurons. Its protein expression is subject to the modulation by acute exposure of amphetamine.
Parelkar
Nikhil K
NK
Department of Pharmacology, School of Pharmacy, University of Missouri-Kansas City, 2411 Holmes Street, Kansas City, Missouri 64108, USA.
Jiang
Qian
Q
Chu
Xiang-Ping
XP
Guo
Ming-Lei
ML
Mao
Li-Min
LM
Wang
John Q
JQ
D000661:Amphetamine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation / Q000187:drug effects*; D007267:Injections; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D017072:Neostriatum / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D011699:Putamen / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D020663:ras Guanine Nucleotide Exchange Factors / Q000378:metabolism; D020666:ras-GRF1 / Q000378:metabolism*
C504492:Rasgrf2 protein, rat; D020663:ras Guanine Nucleotide Exchange Factors; D020666:ras-GRF1; D000661:Amphetamine; D004298:Dopamine
Trends Neurosci. 2006 Nov;29(11):610-6
16956674
Neuroscience. 1990;36(3):669-76
2234405
Synapse. 1996 Feb;22(2):114-22
8787127
Neuroscience. 1993 Apr;53(3):695-703
7683777
Eur J Neurosci. 2004 Mar;19(5):1207-16
15016079
Mol Pharmacol. 2007 Apr;71(4):1148-58
17234898
J Neurosci. 2004 Dec 1;24(48):10846-57
15574735
Neuroscience. 1995 Sep;68(1):83-95
7477938
J Neurosci. 2004 Mar 31;24(13):3344-54
15056714
Neurosci Lett. 1998 Jan 30;241(2-3):95-8
9507929
J Neurosci. 2006 Jan 18;26(3):971-80
16421317
Brain Res Mol Brain Res. 2005 Dec 14;142(2):134-8
16271798
Neuroreport. 2002 Jun 12;13(8):1013-6
12060798
Curr Opin Neurobiol. 2004 Jun;14(3):311-7
15194111
Exp Cell Res. 1997 Aug 25;235(1):117-23
9281359
Nat Neurosci. 2009 May;12(5):602-10
19349975
Biol Cell. 2001 Sep;93(1-2):71-9
11730325
Nature. 1995 Aug 10;376(6540):524-7
7637786
Brain Res Mol Brain Res. 1997 Aug;48(1):140-4
9379834
J Pharmacol Exp Ther. 1995 May;273(2):909-17
7752096
Nat Rev Neurosci. 2004 Mar;5(3):173-83
14976517
Nature. 1992 Jul 23;358(6384):351-4
1379346
Neuron. 2006 Dec 7;52(5):897-909
17145509
Annu Rev Neurosci. 2006;29:565-98
16776597
EMBO J. 1992 Jun;11(6):2151-7
1376246
Neuron. 2009 Feb 12;61(3):425-38
19217379
Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1291-5
1825356
Brain Res. 2003 Nov 14;990(1-2):209-14
14568346
Synapse. 1994 Dec;18(4):343-53
7886627
Neurosci Lett. 2007 Nov 5;427(2):117-21
17931779
J Neurosci. 2000 Dec 1;20(23):8701-9
11102476
EMBO J. 1992 Nov;11(11):4007-15
1396590
Mol Cell Biol. 1997 Mar;17(3):1396-406
9032266
J Neurosci. 2005 Mar 9;25(10):2741-52
15758184
Eur J Neurosci. 2004 Apr;19(7):1826-36
15078556
Mol Cell Biol. 2002 Jun;22(12):4073-85
12024021
J Neurosci. 2006 Feb 8;26(6):1721-9
16467520
J Neurochem. 2007 Jan;100(1):1-11
17018022
Synapse. 1989;4(2):156-61
2781466
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):491-6
15608059
BMC Neurosci. 2006 Mar 02;7:20
16512905
Neuropsychopharmacology. 2002 Oct;27(4):565-75
12377393